ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,854 | -39.7% | 24,628 | -12.0% | 0.00% | – |
| Q4 2022 | $4,735 | -40.8% | 27,971 | -30.3% | 0.00% | – |
| Q3 2022 | $8,000 | -83.0% | 40,106 | -57.2% | 0.00% | -100.0% |
| Q2 2022 | $47,000 | +235.7% | 93,669 | +308.9% | 0.00% | +100.0% |
| Q4 2021 | $14,000 | -68.9% | 22,906 | +64.2% | 0.00% | – |
| Q2 2018 | $45,000 | -39.2% | 13,954 | -16.8% | 0.00% | -100.0% |
| Q4 2017 | $74,000 | +1.4% | 16,780 | +20.1% | 0.00% | -85.7% |
| Q2 2017 | $73,000 | – | 13,968 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROW Partners, LLC | 325,000 | $2,077,000 | 1.27% |
| DAFNA Capital Management LLC | 125,000 | $799,000 | 0.82% |
| BARD ASSOCIATES INC | 170,925 | $1,094,000 | 0.46% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 525,000 | $3,355,000 | 0.36% |
| SOPHROSYNE CAPITAL LLC | 42,000 | $267,000 | 0.23% |
| Granite Point Capital Management, L.P. | 205,000 | $1,310,000 | 0.22% |
| SABBY MANAGEMENT, LLC | 407,024 | $2,601,000 | 0.17% |
| SCOGGIN MANAGEMENT LP | 150,000 | $959,000 | 0.08% |
| Geduld E E | 25,000 | $160,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 45,000 | $288,000 | 0.05% |